| ［1］ Cho BC, Kang SM, Kim DH, et al. Clinical and echocardiographic characteristics of pericardial effusion in patients who underwent echocardiographically guided pericardiocentesis: yonsei cardiovascular center experience, 1993—2003［J］. Yonsei Med J, 2004, 45(3):462-468.
［2］ Little WC, Freeman GL. Pericardial disease［J］. Circulation, 2006, 113(12): 1622-1632.
［3］ Martinoni A, Cipolla CM, Civelli M, et al. Intrapericardial treatment of neoplastic pericardial effusions［J］. Herz, 2000, 25(8): 787-793.
［4］ Tsang TS, EnriquezSarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years［J］. Mayo Clin Proc, 2002, 77(5): 429-436.
［5］ 石旦, 沈月平, 裴红蕾, 等. 细胞因子诱导的杀伤细胞治疗胃癌对其无瘤生存的影响［J］. 中华实验外科杂志, 2012, 29(3): 395-397.
［6］ 张澎, 张静, 刘亮, 等. CIK治疗转移性肾癌的临床疗效评价及预后影响因素分析［J］. 中国肿瘤临床, 2012, 29(10): 732-735.
［7］ 刘红伟, 孟明耀, 解燕华, 等. 不同疗程CIK治疗患者的CIK细胞的细胞毒活性研究［J］. 昆明医学院学报, 2010, 31(12): 37-40.
［8］ Rowinsky EK, Grochow LB, Hendricks CB, et al. Phase Ⅰ and pharmacologic study of topotecan: a novel topoisomerase Ⅰ inhibitor［J］. J Clin Oncol, 1992, 10(4): 647-656.
［9］ 施玲燕, 刘继斌, 刘晓玲, 等. CIK细胞实验研究及治疗肿瘤的临床疗效观察［J］. 肿瘤基础与临床, 2009, 22(2):141-143.
［10］ Zhong R, Teng J, Han B, et al. Dendritic cells combining with cytokineinduced killer cells synergize chemotherapy in patients with latestage nonsmall cell lung cancer［J］. Cancer Immunol Lmmunother, 2011, 60(10):1497-1502.
［11］ Liu L, Zhang W, Qi X, et al. Randomized study of autologous cytokineinduced killer cell immunotherapy in metastatic renal carcinoma［J］. Clin Cancer Res, 2012, 18(6):1751-1759.
［12］ Shi L, Zhou Q, Wu J, et al. Efficacy of adjuvant immunotherapy with cytokineinduced killer cells in patients with locally advanced gastric cancer ［J］. Cancer Immunol Immunother, 2012, 61(12):2251-2259. |
